HUP9901717A2 - Eljárás enantiomer-dúsított benzimidazolszármazékok optikai tisztítására - Google Patents

Eljárás enantiomer-dúsított benzimidazolszármazékok optikai tisztítására

Info

Publication number
HUP9901717A2
HUP9901717A2 HU9901717A HUP9901717A HUP9901717A2 HU P9901717 A2 HUP9901717 A2 HU P9901717A2 HU 9901717 A HU9901717 A HU 9901717A HU P9901717 A HUP9901717 A HU P9901717A HU P9901717 A2 HUP9901717 A2 HU P9901717A2
Authority
HU
Hungary
Prior art keywords
benzimidazole derivatives
enantiomerically enriched
optical purification
benzimidazole
enantiomer
Prior art date
Application number
HU9901717A
Other languages
English (en)
Inventor
Sverker Unge
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20397468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP9901717(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of HUP9901717A2 publication Critical patent/HUP9901717A2/hu
Publication of HUP9901717A3 publication Critical patent/HUP9901717A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

A találmány tárgya eljárás biőlógiailag aktív benzimidazőlszármazékők, példáűl őmeprazől, lansőprazől, pariprazől stb.enantiőmer-dúsítőtt racém keverékeinek őptikai tisztítására, amelybena megfelelő racém benzimidazőlt egy őldószerrel vagy több őldószerelegyével kezelik. A kezelés eredményeképpen a racemát kiválik, éskiszűrés űtán a szűrletből az őldószert eltávőlítva maradékként amegfelelő benzimidazőlszármazék (-)- vagy (+)-enantiőmerében dúsítőttanyagőt kapnak. ŕ
HU9901717A 1995-07-03 1996-06-26 A process for the optical purification of enantiomerically enriched benzimidazole derivatives HUP9901717A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500817 1995-07-03

Publications (2)

Publication Number Publication Date
HUP9901717A2 true HUP9901717A2 (hu) 2000-04-28
HUP9901717A3 HUP9901717A3 (en) 2002-03-28

Family

ID=20397468

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901717A HUP9901717A3 (en) 1995-07-03 1996-06-26 A process for the optical purification of enantiomerically enriched benzimidazole derivatives

Country Status (37)

Country Link
US (1) US5929244A (hu)
EP (2) EP1498416A1 (hu)
JP (1) JP4195507B2 (hu)
KR (1) KR100451078B1 (hu)
CN (1) CN1098261C (hu)
AT (1) ATE418549T1 (hu)
AU (1) AU698638B2 (hu)
BR (1) BR9609450A (hu)
CA (1) CA2226184C (hu)
CZ (1) CZ295430B6 (hu)
DE (1) DE69637788D1 (hu)
DK (1) DK0836601T3 (hu)
DZ (1) DZ2057A1 (hu)
EE (1) EE03444B1 (hu)
ES (1) ES2318850T3 (hu)
HK (1) HK1010193A1 (hu)
HR (1) HRP960232A2 (hu)
HU (1) HUP9901717A3 (hu)
IL (1) IL122811A (hu)
IS (1) IS2666B (hu)
MA (1) MA23921A1 (hu)
MY (1) MY114018A (hu)
NO (1) NO313008B1 (hu)
NZ (1) NZ311842A (hu)
PL (1) PL186702B1 (hu)
PT (1) PT836601E (hu)
RS (1) RS49826B (hu)
RU (1) RU2144031C1 (hu)
SA (1) SA96170103B1 (hu)
SI (1) SI0836601T1 (hu)
SK (1) SK284780B6 (hu)
TN (1) TNSN96090A1 (hu)
TR (1) TR199701754T1 (hu)
TW (1) TW444010B (hu)
UA (1) UA49838C2 (hu)
WO (1) WO1997002261A1 (hu)
ZA (1) ZA965205B (hu)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
EP0983263A1 (en) * 1997-05-30 2000-03-08 Dr. Reddy's Research Foundation Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
JP2002501897A (ja) * 1998-01-30 2002-01-22 セプラコール， インク． Ｒ−ランソプラゾール組成物及び方法
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
TWI289557B (en) 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
DE60020967T2 (de) 1999-06-30 2006-05-04 Takeda Pharmaceutical Co. Ltd. Kristalle von lansoprazole
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
DE60131649T2 (de) 2000-05-15 2008-10-30 Takeda Pharmaceutical Co. Ltd. Verfahren zur herstellung eines kristalls
CA2417311C (en) 2000-08-04 2012-07-10 Takeda Chemical Industries, Ltd. Crystalline alkali metal salts of lansoprazole and their production and use
KR20100002278A (ko) 2000-12-01 2010-01-06 다케다 야쿠힌 고교 가부시키가이샤 (ｒ)- 또는 (ｓ)-란소프라졸의 결정
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
SE0104295D0 (sv) * 2001-12-18 2001-12-18 Astrazeneca Ab New process
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8697094B2 (en) 2002-10-16 2014-04-15 Takeda Pharmaceutical Company Limited Stable solid preparations
DE10254167A1 (de) 2002-11-20 2004-06-09 Icon Genetics Ag Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
MXPA05005762A (es) 2002-12-06 2005-08-16 Altana Pharma Ag Procedimiento para preparar compuestos activos opticamente puros.
PL375695A1 (en) 2002-12-06 2005-12-12 Altana Pharma Ag Process for preparing (s)-pantoprazole
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
CA2517714A1 (en) * 2003-02-28 2004-09-10 Ranbaxy Laboratories Limited Polymorphs of s-omeprazole
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7005732B2 (en) * 2003-10-21 2006-02-28 Honeywell International Inc. Methods and systems for providing MEMS devices with a top cap and upper sense plate
FR2863609A1 (fr) * 2003-12-15 2005-06-17 Isochem Sa Procede d'enrichissement enantiomerique d'un melange d'enantiomeres d'alpha-aminoacides
SE0400410D0 (sv) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1768668A2 (en) 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
FR2909380B1 (fr) * 2006-12-04 2009-02-20 Sidem Pharma Sa Sa Conglomerats de sels de potassium de tenatoprazole
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
CN101323609B (zh) * 2007-06-15 2013-05-01 成都福瑞生物工程有限公司 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
KR101432866B1 (ko) * 2007-06-15 2014-08-26 엠큐어 파마슈티컬즈 리미티드 생활성 화합물의 설폭사이드화 방법
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
PE20091680A1 (es) 2008-03-10 2009-11-16 Takeda Pharmaceutical Cristal de compuestos de bencimidazol
WO2010058409A2 (en) 2008-11-18 2010-05-27 Hetero Research Foundation Optical purification of esomeprazole
KR101001646B1 (ko) * 2008-12-12 2010-12-17 한미약품 주식회사 (ｒ)-(+)-란소프라졸의 제조방법 및 이에 사용되는 중간체
WO2011004387A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
US8748619B2 (en) 2009-11-12 2014-06-10 Hetero Research Foundation Process for the resolution of omeprazole
AU2011210328A1 (en) 2010-01-29 2012-08-16 Ranbaxy Laboratories Limited Process for the preparation of crystalline forms of dexlansoprazole
US10071996B2 (en) 2014-07-30 2018-09-11 Aetas Pharma Co., Ltd. Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same
EP3064495B1 (en) 2015-03-06 2016-12-14 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of optically pure esomeprazole

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) * 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
ES2057338T3 (es) * 1989-11-29 1994-10-16 Toa Eiyo Ltd Derivados de cicloheptenopiridina, procedimiento para su preparacion y agentes antiulcerosos que los contienen.
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds

Also Published As

Publication number Publication date
DK0836601T3 (da) 2009-03-16
IL122811A (en) 2000-11-21
JP4195507B2 (ja) 2008-12-10
RS49826B (sr) 2008-08-07
UA49838C2 (uk) 2002-10-15
EP1498416A1 (en) 2005-01-19
IS2666B (is) 2010-08-15
SK179397A3 (en) 1998-09-09
EE03444B1 (et) 2001-06-15
JPH11508590A (ja) 1999-07-27
CZ421197A3 (cs) 1998-06-17
HK1010193A1 (en) 1999-06-17
TW444010B (en) 2001-07-01
HRP960232A2 (en) 1998-02-28
IS4638A (is) 1997-12-22
CN1098261C (zh) 2003-01-08
YU37696A (sh) 1999-03-04
SI0836601T1 (sl) 2009-04-30
EP0836601B1 (en) 2008-12-24
EE9700368A (et) 1998-06-15
NZ311842A (en) 1998-12-23
TNSN96090A1 (fr) 2005-03-15
NO976030D0 (no) 1997-12-22
MX9800160A (es) 1998-03-31
KR19990028631A (ko) 1999-04-15
IL122811A0 (en) 1998-08-16
PL324394A1 (en) 1998-05-25
SK284780B6 (sk) 2005-11-03
DE69637788D1 (de) 2009-02-05
WO1997002261A1 (en) 1997-01-23
ES2318850T3 (es) 2009-05-01
RU2144031C1 (ru) 2000-01-10
PT836601E (pt) 2009-02-17
AU6324096A (en) 1997-02-05
HUP9901717A3 (en) 2002-03-28
BR9609450A (pt) 1999-03-02
KR100451078B1 (ko) 2004-11-16
DZ2057A1 (fr) 2002-10-20
EP0836601A1 (en) 1998-04-22
CA2226184C (en) 2008-08-05
NO976030L (no) 1998-02-09
MA23921A1 (fr) 1996-12-31
ZA965205B (en) 1997-01-03
PL186702B1 (pl) 2004-02-27
ATE418549T1 (de) 2009-01-15
US5929244A (en) 1999-07-27
MY114018A (en) 2002-07-31
CN1193971A (zh) 1998-09-23
CA2226184A1 (en) 1997-01-23
NO313008B1 (no) 2002-07-29
TR199701754T1 (xx) 1998-04-21
SA96170103B1 (ar) 2006-07-30
CZ295430B6 (cs) 2005-08-17
AU698638B2 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
HUP9901717A2 (hu) Eljárás enantiomer-dúsított benzimidazolszármazékok optikai tisztítására
NO983636D0 (no) Fremgangsmåte for behandling av trekninger og sykdomstilstander i sentralnervesystemet ved anvendelse av optisk rent (+) norcisaprid
DE69728730D1 (de) Verfahren zur Trennung einer Enantiomermischung
DE602004020263D1 (de) Amino-substituierte diaryläa,dücyclohepten- analoga als muscarinische agonisten und verfahren zur behandlung von neuropsychiatrischen erkrankungen
DE69532137D1 (de) Verbessertes verfahren zur stabilisierung biologischer substanzen während der trocknung und anschliessender lagerung sowie die entsprechenden zusammensetzungen
DK0694542T3 (da) Fremgangsmåde til racemerisering af enantiomerer af alfa-liponsyre
ATE278391T1 (de) Verfahren zur herstellung kristalliner partikel
DE69633016D1 (de) Optisch reines (-) norcisaprid zur behandlung von krankheiten des verdauungstrakt
DE69525950D1 (de) Racemisierungsverfahren bei der herstellung von levobupivacaine und analogen
NO964346D0 (no) Fremgangsmåte for opplösning av Etodolac ved bruk av glukaminderivater
ATE169294T1 (de) Verbindungen zur behandlung von bauchentzündungen
DE59601715D1 (de) Verfahren zur Herstellung von Faserfiltern
ATE155456T1 (de) Verfahren zur herstellung und optischen auflösung von 2-phenyl-3-aminopiperidine
DE69918322D1 (de) Verwendung von optisch reinem (r)-tofizopam zur behandlung und pravention von angststörungen
DE69432626D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen
DE69016531D1 (de) 2,3-Dihydro-1-(pyridinylamino)-indole, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel.
DE69607113D1 (de) Verfahren zur Racemisierung von optisch aktiven 1-Phenylethylamin-Derivaten
DE69300471D1 (de) Verfahren zur Herstellung von Derivaten der epoxypropionsäure.
DE69722538D1 (de) Verfahren zur Herstellung von optisch aktiver Azetidin-2-Carbonsäure
ATE230303T1 (de) Behandlung von flachs-saatgut
NO990436L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
ATE196085T1 (de) Verfahren und zusammensetzung zur behandlung von infektionen unter verwendung von optisch reinem (r) - lomefloxacin
ATE334669T1 (de) Verfahren zur herstellung eines extraktes aus copalchirinde und verwendung der neoflavonoide zur behandlung von diabetes
ATE200664T1 (de) Neue enantiomerenreine pyridylcycloalkylethylamine und deren salze sowie verfahren zu ihrer herstellung
DK0784603T3 (da) Racemisering af forstadier for levobupivacain og analoge forstadier heraf

Legal Events

Date Code Title Description
FC4A Lapse of provisional application due to refusal